Skip to main navigation Skip to search Skip to main content

Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?

  • Alessandra Tedeschi*
  • , Anna Maria Frustaci
  • , Francesca Romana Mauro
  • , Annalisa Chiarenza
  • , Marta Coscia
  • , Stefania Ciolli
  • , Gianluigi Reda
  • , Luca Laurenti
  • , Marzia Varettoni
  • , Roberta Murru
  • , Claudia Baratè
  • , Paolo Sportoletti
  • , Antonino Greco
  • , Chiara Borella
  • , Valentina Rossi
  • , Marina Deodato
  • , Annalisa Biagi
  • , Giulia Zamprogna
  • , Angelo Curto Pelle
  • , Gianfranco Lapietra
    • Candida Vitale, Francesca Morelli, Ramona Cassin, Alberto Fresa, Chiara Cavalloni, Massimiliano Postorino, Claudia Ielo, Roberto Cairoli, Francesco Di Raimondo, Marco Montillo, Giovanni Del Poeta
*Corresponding author

Research output: Contribution to journal › Article

Abstract

n/a
Original languageEnglish
Pages (from-to)N/A-N/A
JournalBlood advances
Issue numberseptember 2021
DOIs
Publication statusPublished - 2021

All Science Journal Classification (ASJC) codes

  • Hematology

Keywords

  • chronic lymphocytic leukaemia

Access to Document

Other files and links

Fingerprint

Dive into the research topics of 'Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib?'. Together they form a unique fingerprint.
View full fingerprint

Cite this